Page last updated: 2024-08-21

fluorobenzenes and Cardiac Failure

fluorobenzenes has been researched along with Cardiac Failure in 83 studies

Research

Studies (83)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	42 (50.60)	29.6817
2010's	41 (49.40)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Jhund, P; Kjekshus, J; McMurray, JJ; Perez, AC; Preiss, D	1
Aukrust, P; Fucili, A; Grosu, A; Gullestad, L; Kjekshus, J; Latini, R; Maggioni, AP; Masson, S; McMurray, JJ; Nymo, SH; Ueland, T; Yndestad, A	1
Askevold, ET; Aukrust, P; Gravning, J; Gullestad, L; Kjekshus, J; McMurray, JJ; Nymo, SH; Ueland, T; Wikstrand, J	1
Aakhus, S; Andreassen, J; Askevold, ET; Aukrust, P; Broch, K; Gjertsen, E; Godang, K; Gullestad, L; Smith, HJ; Stueflotten, W; Svendsmark, R; Ueland, T; Yndestad, A	1
Cleland, JG; Gullestad, L; Jhund, PS; Kjekshus, J; McMurray, JJ; Perez, AC; Stott, DJ; van Veldhuisen, DJ; Wikstrand, J	1
Böhm, M; Cleland, JG; Gullestad, L; Jhund, PS; Kjekshus, J; Lewsey, JD; Macdonald, MR; McMurray, JJ; Perez-Moreno, AC; Petrie, MC; van Veldhuisen, DJ; Wikstrand, J	1
Böhm, M; Cleland, JG; Gullestad, L; Jhund, PS; Kjekshus, J; McMurray, JJ; Perez, AC; Pocock, SJ; Rogers, JK; van Veldhuisen, DJ; Wedel, H; Wikstrand, J	1
Badar, AA; Cleland, JG; Gardner, RS; Hawkins, NM; Jhund, PS; Kjekshus, J; McMurray, JJ; Perez-Moreno, AC; Petrie, MC; van Veldhuisen, DJ; Watkins, S; Wedel, H; Wikstrand, J; Wong, CM	1
Carson, PE; Granger, CB; Jhund, PS; Kjekshus, J; Komajda, M; Kristensen, SL; Køber, L; McKelvie, RS; McMurray, JJ; Pfeffer, MA; Solomon, SD; Swedberg, K; Wedel, H; Wikstrand, J; Yusuf, S; Zile, MR	1
Rossignol, P; Zannad, F	1
Homma, S; Ye, S	1
Abdul-Rahim, AH; Fulton, RL; Jhund, PS; Kjekshus, J; Latini, R; Lees, KR; Lip, GY; Maggioni, AP; McMurray, JJ; Perez, AC; Tavazzi, L; Tognoni, G; Wikstrand, J	2
Hung, Y; Li, YH; Lin, GM	1
Serebruany, VL	1
Erdmann, E; Hoppe, UC	1
Katz, SD	1
Ford, JS; Tayek, JA	1
Bérard, A; Blais, L; Dragomir, A; Lalonde, L; Perreault, S; White, M	1
Barlera, S; Franzosi, MG; Latini, R; Lucci, D; Maggioni, AP; Marchioli, R; Nicolosi, GL; Porcu, M; Tavazzi, L; Tognoni, G	1
Capurso, A; Capurso, C; Colacicco, AM; D'Introno, A; Frisardi, V; Gadaleta, A; Panza, F; Santamato, A; Solfrizzi, V	1
Clark, AL; Cleland, JG; Coletta, AP; Cullington, D	1
Elder, D; Kalra, P; Lang, CC; Pauriah, M	1
Cleland, JG; Cornel, JH; Dunselman, P; Hjalmarson, A; Kjekshus, J; Komajda, M; Kuusi, T; Lindberg, M; McMurray, JJ; Vanhaecke, J; Waagstein, F; Wedel, H; Wikstrand, J	1
Capurso, A; Capurso, C; Panza, F; Solfrizzi, V; Vendemiale, G	1
Antoniades, C; Gounari, P; Kampoli, AM; Papageorgiou, N; Roulia, G; Siasos, G; Stefanadi, E; Stefanadis, C; Stougiannos, P; Tousoulis, D; Tsioufis, C	1
Hoppe, UC; Nitschmann, S	1
Nodari, S; Tavazzi, L	1
Fabbri, G; Maggioni, AP	1
Preorazhenskiĭ, DV	1
Karelkina, EV; Moiseeva, OM; Moroshkin, VS; Seliutin, AV; Shliakhto, EV	1
Andreou, I; Antoniades, C; Charakida, M; Gounari, P; Kotrogiannis, I; Miliou, A; Papageorgiou, N; Stefanadis, C; Tentolouris, C; Tousoulis, D; Trikas, A	1
Roik, M	1
Chang, HJ; Chang, SA; Kim, DH; Kim, HK; Kim, YJ; Lee, HW; Oh, BH; Park, YB; Sohn, DW	1
Brown, L; Chan, V; Hoey, A; Loch, D	1
Barlera, S; Bernardinangeli, M; Carbonieri, E; Cosmi, F; Franzosi, MG; Latini, R; Levantesi, G; Lucci, D; Maggioni, AP; Marchioli, R; Moretti, L; Nicolosi, GL; Porcu, M; Rossi, MG; Silletta, MG; Tavazzi, L; Tognoni, G	1
Cosmi, F; Fabbri, G; Franzosi, MG; Latini, R; Lucci, D; Maggioni, AP; Marchioli, R; Nicolosi, GL; Porcu, M; Stefanelli, S; Tavazzi, L; Tognoni, G	1
Hradec, J	1
Fujii, M; Horie, M; Kawahara, C; Nishiyama, K; Tsutamoto, T; Yamaji, M; Yamamoto, T	1
Cleland, JG; Cornel, JH; Dunselman, P; Fonseca, C; Hjalmarson, A; Kjekshus, J; Korewicki, J; Lindberg, M; McMurray, JJ; Ranjith, N; van Veldhuisen, DJ; Waagstein, F; Wedel, H; Wikstrand, J	1
Barrett-Connor, E; Daniels, LB	1
Barrios, V; Escobar, C	2
Andreou, I; Dimopoulos, MA; Gounari, P; Miliou, A; Papadimitriou, CA; Papageorgiou, N; Siasos, G; Stefanadis, C; Tentolouris, C; Tousoulis, D; Zisimos, K	1
Barrios, V; Briggs, AH; Dunselman, P; Fonseca, C; Hjalmarson, A; Jánosi, A; Kjekshus, J; Lorgelly, PK; McMurray, JJ; van Veldhuisen, DJ; Waagstein, F; Wedel, H; Wikstrand, J	1
Ashton, E; Krum, H; Reid, C; Rosenfeldt, F; Schneider, H; Skiba, M; Tonkin, A; Windebank, E	1
Eren, M	1
Dunselman, PH; Slart, RH; Tio, RA; van den Heuvel, AF; van der Harst, P; van Veldhuisen, DJ; Voors, AA; Willemsen, AT	1
Adams, V; Beck, EB; Erbs, S; Gielen, S; Hambrecht, R; Höllriegel, R; Kränkel, N; Linke, A; Möbius-Winkler, S; Schuler, G; Thiele, H	1
Yalta, K	1
Aragoncillo, P; Caro-Vadillo, A; Fernández-Cruz, A; Gómez-Garre, D; González-Rubio, ML; Muñoz-Pacheco, P	1
Bjerre, M; Di Tano, G; Flyvbjerg, A; Latini, R; Maggioni, AP; Masson, S; Milani, V; Misuraca, G; Omland, T; Røysland, R; Tavazzi, L; Tognoni, G	1
Bugan, B; Celik, T	1
Felker, GM	1
Apetrei, E; Barrios, V; Böhm, M; Cleland, JG; Dunselman, P; Hjalmarson, A; Kamenský, G; Kjekshus, J; Komajda, M; Lindberg, M; Mareev, V; McMurray, JJ; Waagstein, F; Wedel, H; Wikstrand, J	1
Eleuteri, E; Ghio, S; Gorini, M; Latini, R; Maggioni, A; Marchioli, R; Masson, S; Palvarini, M; Pasotti, M; Scelsi, L; Tavazzi, L; Vriz, O	1
Andreou, I; Dimopoulos, MA; Miliou, A; Papadimitriou, CA; Papageorgiou, N; Siasos, G; Stefanadis, C; Tentolouris, C; Tousoulis, D; Tsiatas, M	1
Aukrust, P; Böhm, M; Dahl, CP; Goudev, A; Gullestad, L; Hulthe, J; Kjekshus, J; Lindberg, M; Mach, F; Ueland, T; Wikstrand, J	1
Mortensen, SA	1
Azure, M; Bozek, J; Broekema, M; Casebier, D; Cdebaca, M; Cesati, R; Guaraldi, M; Kagan, M; Lamoy, M; Lazewatsky, J; Mistry, M; Onthank, D; Purohit, A; Radeke, H; Robinson, SP; Silva, P; Yalamanchili, P; Yu, M	1
Takagi, H; Umemoto, T	1
Askevold, ET; Aukrust, P; Flo, TH; Gullestad, L; Hulthe, J; Kjekshus, J; McMurray, J; Nymo, SH; Ueland, T; Van Veldhuisen, DJ; Wikstrand, J; Yndestad, A	1
Aukrust, P; Bottazzi, B; Cuccovillo, I; Gullestad, L; Latini, R; Lucci, D; Mantovani, A; Masson, S; Masuda, N; Nymo, SH; Sudo, Y; Tavazzi, L; Tognoni, G; Ueland, T; Vårdal, M; Wikstrand, J	1
Bao, Z; Du, Q; Fan, F; Ge, J; Hu, X; Li, H; Li, Z; Qiu, Z; Sun, A; Wu, C; Ye, Y; Zhang, W; Zhao, G	1
Gupta, RC; Mishra, S; Rastogi, S; Sabbah, HN; Zacà, V	1
Askevold, ET; Aukrust, P; Cleland, JG; Gravning, J; Gullestad, L; Kjekshus, J; McMurray, JJ; Nymo, S; Ueland, T; Wergeland, R; Yndestad, A	1
Chello, M; Spadaccio, C	1
DiNicolantonio, JJ; Lavie, CJ; O'Keefe, JH; Serebruany, VL	1
Dunselman, P; Hjalmarson, A; Kjekshus, J; McMurray, J; Waagstein, F	1
Franzosi, MG; Latini, R; Maggioni, AP; Marchioli, R; Nicolosi, GL; Porcu, M; Tavazzi, L; Tognoni, G	1
Bauersachs, J; Eigenthaler, M; Ertl, G; Firnschild, A; Fraccarollo, D; Frantz, S; Schäfer, A; Tas, P	1
Blideskog, M; Dunselman, P; Eskilson, C; Hjalmarson, A; Kjekshus, J; McMurray, JV; Waagstein, F; Wedel, H; Wessman, P; Wikstrand, J	1
Mareev, VIu	2
Clark, AL; Cleland, JG; Coletta, AP; Nikitin, NP	1
Amarena, J; Ashton, E; Kalff, V; Krum, H; Reid, C; Rogers, J; Singh, B; Tonkin, A	1
Goldstein, S; Imai, M; Jiang, A; Rastogi, S; Sabbah, HN; Sharov, VG; Wang, M; Zacà, V	1
Apetrei, E; Barrios, V; Böhm, M; Cleland, JG; Cornel, JH; Dunselman, P; Fonseca, C; Goudev, A; Grande, P; Gullestad, L; Hjalmarson, A; Hradec, J; Jánosi, A; Kamenský, G; Kjekshus, J; Komajda, M; Korewicki, J; Kuusi, T; Mach, F; Mareev, V; McMurray, JJ; Ranjith, N; Schaufelberger, M; van Veldhuisen, DJ; Vanhaecke, J; Waagstein, F; Wedel, H; Wikstrand, J	1
Masoudi, FA	1
Abdellah, AT; Clark, AL; Cleland, JG; Coletta, AP; Cullington, D; Rigby, AS	1
Florkowski, CM; George, PM; Molyneux, SL	1
Stalenhoef, AF	1
Angermann, CE; Nitschmann, S	1

Reviews

10 review(s) available for fluorobenzenes and Cardiac Failure

Article	Year
Risk of Stroke in Chronic Heart Failure Patients Without Atrial Fibrillation: Analysis of the Controlled Rosuvastatin in Multinational Trial Heart Failure (CORONA) and the Gruppo Italiano per lo Studio della Sopravvivenza nell'Insufficienza Cardiaca-Heart Circulation, 2015, Apr-28, Volume: 131, Issue:17 Topics: Adult; Aged; Aged, 80 and over; Atrial Fibrillation; Benzimidazoles; Biomarkers; Biphenyl Compounds; Cardiovascular Agents; Diabetes Mellitus, Type 1; Fatty Acids, Omega-3; Female; Fluorobenzenes; Follow-Up Studies; Heart Failure; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kaplan-Meier Estimate; Male; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments; Proportional Hazards Models; Pyrimidines; Randomized Controlled Trials as Topic; Risk Factors; Rosuvastatin Calcium; Stroke; Stroke Volume; Sulfonamides; Tetrazoles	2015
[Cardiology 2008]. Deutsche medizinische Wochenschrift (1946), 2008, Volume: 133, Issue:25-26 Topics: Anticholesteremic Agents; Antihypertensive Agents; Aortic Valve Stenosis; Cardiac Catheterization; Cardiovascular Diseases; Drug Therapy, Combination; Electrocardiography; Fluorobenzenes; Heart Failure; Heart Valve Prosthesis Implantation; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hypertension; Myocardial Infarction; Platelet Aggregation Inhibitors; Pyrimidines; Randomized Controlled Trials as Topic; Rosuvastatin Calcium; Sulfonamides	2008
Potential role of statins in the treatment of heart failure. Current atherosclerosis reports, 2008, Volume: 10, Issue:4 Topics: Fluorobenzenes; Heart Failure; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Pyrimidines; Rosuvastatin Calcium; Sulfonamides	2008
Cardiovascular risk reduction: what do recent trials with rosuvastatin tell us? Advances in therapy, 2009, Volume: 26, Issue:5 Topics: Cardiovascular Diseases; Cholesterol, HDL; Cholesterol, LDL; Clinical Trials as Topic; Disease Progression; Evidence-Based Medicine; Fluorobenzenes; Heart Failure; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Inflammation; Kidney Failure, Chronic; Practice Guidelines as Topic; Primary Prevention; Pyrimidines; Risk Factors; Risk Reduction Behavior; Rosuvastatin Calcium; Sulfonamides; Treatment Outcome	2009
[To treat or not to treat with statins patients with chronic heart failure?]. Vnitrni lekarstvi, 2009, Volume: 55, Issue:9 Topics: Fluorobenzenes; Heart Failure; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Pyrimidines; Rosuvastatin Calcium; Sulfonamides	2009
Rosuvastatin along the cardiovascular continuum: from JUPITER to AURORA. Expert review of cardiovascular therapy, 2009, Volume: 7, Issue:11 Topics: Atherosclerosis; Cardiovascular Diseases; Cholesterol, HDL; Cholesterol, LDL; Clinical Trials as Topic; Fluorobenzenes; Heart Failure; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney Failure, Chronic; Primary Prevention; Pyrimidines; Risk Factors; Rosuvastatin Calcium; Sulfonamides	2009
[The role of statins in the treatment of heart failure]. Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir, 2009, Volume: 37, Issue:7 Topics: Cardiovascular Diseases; Coronary Disease; Fluorobenzenes; Heart Failure; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Pyrimidines; Randomized Controlled Trials as Topic; Rosuvastatin Calcium; Sulfonamides	2009
Atorvastatin, not rosuvastatin, improves cardiac function in heart failure: a meta-analysis of randomized trials. International journal of cardiology, 2012, Mar-08, Volume: 155, Issue:2 Topics: Atorvastatin; Fluorobenzenes; Heart Failure; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Pyrimidines; Pyrroles; Randomized Controlled Trials as Topic; Rosuvastatin Calcium; Stroke Volume; Sulfonamides	2012
Statin wars: the heavyweight match--atorvastatin versus rosuvastatin for the treatment of atherosclerosis, heart failure, and chronic kidney disease. Postgraduate medicine, 2013, Volume: 125, Issue:1 Topics: Atherosclerosis; Atorvastatin; Fluorobenzenes; Heart Failure; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Pyrimidines; Pyrroles; Renal Insufficiency, Chronic; Rosuvastatin Calcium; Sulfonamides	2013
[Treatment of chronic heart failure. The time of statins?]. Kardiologiia, 2005, Volume: 45, Issue:12 Topics: Aged; Animals; Anticholesteremic Agents; Cholesterol; Controlled Clinical Trials as Topic; Costs and Cost Analysis; Disease Models, Animal; Female; Fluorobenzenes; Heart Failure; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hypolipidemic Agents; Male; Prognosis; Pyrimidines; Risk Factors; Rosuvastatin Calcium; Simvastatin; Sulfonamides; Time Factors	2005

Trials

33 trial(s) available for fluorobenzenes and Cardiac Failure

Article	Year
CCL21 is associated with fatal outcomes in chronic heart failure: data from CORONA and GISSI-HF trials. European journal of heart failure, 2013, Volume: 15, Issue:7 Topics: Aged; Chemokine CCL21; Disease Progression; Double-Blind Method; Female; Fluorobenzenes; Heart Failure; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kaplan-Meier Estimate; Male; Norway; Prognosis; Proportional Hazards Models; Pyrimidines; Risk Factors; Rosuvastatin Calcium; Sulfonamides; Survival Rate; Treatment Outcome	2013
Prognostic effect of high-sensitive troponin T assessment in elderly patients with chronic heart failure: results from the CORONA trial. Circulation. Heart failure, 2014, Volume: 7, Issue:1 Topics: Aged; Aged, 80 and over; Anticholesteremic Agents; Biomarkers; C-Reactive Protein; Chronic Disease; Female; Fluorobenzenes; Follow-Up Studies; Heart Failure; Humans; Male; Middle Aged; Myocardial Infarction; Natriuretic Peptide, Brain; Peptide Fragments; Predictive Value of Tests; Prognosis; Pyrimidines; Risk Factors; Rosuvastatin Calcium; Sensitivity and Specificity; Stroke; Sulfonamides; Survival Rate; Troponin T	2014
The effect of rosuvastatin on inflammation, matrix turnover and left ventricular remodeling in dilated cardiomyopathy: a randomized, controlled trial. PloS one, 2014, Volume: 9, Issue:2 Topics: Adult; Aged; Cardiomyopathy, Dilated; Cholesterol, LDL; Extracellular Matrix; Female; Fluorobenzenes; Heart Failure; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Male; Middle Aged; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Ventricular Function, Left; Ventricular Remodeling	2014
Thyroid-stimulating hormone and clinical outcomes: the CORONA trial (controlled rosuvastatin multinational study in heart failure). JACC. Heart failure, 2014, Volume: 2, Issue:1 Topics: Aged; Analysis of Variance; Biomarkers; Drug Administration Schedule; Female; Fluorobenzenes; Heart Failure; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Natriuretic Peptides; Pyrimidines; Rosuvastatin Calcium; Stroke Volume; Sulfonamides; Thyroid Diseases; Thyrotropin; Treatment Outcome	2014
Fatigue as a predictor of outcome in patients with heart failure: analysis of CORONA (Controlled Rosuvastatin Multinational Trial in Heart Failure). JACC. Heart failure, 2014, Volume: 2, Issue:2 Topics: Aged; Dyspnea; Fatigue; Female; Fluorobenzenes; Heart Failure; Hospitalization; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Pyrimidines; Rosuvastatin Calcium; Stroke Volume; Sulfonamides; Treatment Outcome	2014
Effect of rosuvastatin on repeat heart failure hospitalizations: the CORONA Trial (Controlled Rosuvastatin Multinational Trial in Heart Failure). JACC. Heart failure, 2014, Volume: 2, Issue:3 Topics: Aged; Chronic Disease; Epidemiologic Methods; Female; Fluorobenzenes; Heart Failure; Hospitalization; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Myocardial Infarction; Myocardial Ischemia; Pyrimidines; Recurrence; Rosuvastatin Calcium; Sulfonamides	2014
Relationship between angina pectoris and outcomes in patients with heart failure and reduced ejection fraction: an analysis of the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA). European heart journal, 2014, Dec-21, Volume: 35, Issue:48 Topics: Aged; Angina Pectoris; Female; Fluorobenzenes; Heart Failure; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kaplan-Meier Estimate; Male; Middle Aged; Pyrimidines; Retrospective Studies; Rosuvastatin Calcium; Stroke Volume; Sulfonamides; Treatment Outcome; Ventricular Dysfunction, Left	2014
International geographic variation in event rates in trials of heart failure with preserved and reduced ejection fraction. Circulation, 2015, Jan-06, Volume: 131, Issue:1 Topics: Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Biphenyl Compounds; Canada; Europe; Female; Fluorobenzenes; Geography; Heart Failure; Hospitalization; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Irbesartan; Male; Middle Aged; Pyrimidines; Risk Factors; Rosuvastatin Calcium; Russia; Stroke Volume; Sulfonamides; Tetrazoles; Treatment Outcome; United States	2015
Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial. Lancet (London, England), 2008, Oct-04, Volume: 372, Issue:9645 Topics: Aged; Chronic Disease; Double-Blind Method; Female; Fluorobenzenes; Heart Failure; Hospitalization; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Italy; Male; Proportional Hazards Models; Pyrimidines; Rosuvastatin Calcium; Sulfonamides	2008
Predictors of fatal and non-fatal outcomes in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA): incremental value of apolipoprotein A-1, high-sensitivity C-reactive peptide and N-terminal pro B-type natriuretic peptide. European journal of heart failure, 2009, Volume: 11, Issue:3 Topics: Administration, Oral; Aged; Apolipoprotein A-I; Biomarkers; C-Reactive Protein; Cause of Death; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fluorobenzenes; Heart Failure; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Natriuretic Peptide, Brain; Nephelometry and Turbidimetry; Peptide Fragments; Prognosis; Protein Precursors; Pyrimidines; Risk Factors; Rosuvastatin Calcium; Sulfonamides; Survival Rate	2009
Rosuvastatin but not ezetimibe improves endothelial function in patients with heart failure, by mechanisms independent of lipid lowering. International journal of cardiology, 2010, Jun-25, Volume: 142, Issue:1 Topics: Azetidines; Cross-Over Studies; Double-Blind Method; Endothelium, Vascular; Ezetimibe; Female; Fluorobenzenes; Heart Failure; Humans; Lipids; Male; Middle Aged; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Vasodilation	2010
Comparative effects of rosuvastatin and allopurinol on circulating levels of matrix metalloproteinases and tissue inhibitors of metalloproteinases in patients with chronic heart failure. International journal of cardiology, 2010, Dec-03, Volume: 145, Issue:3 Topics: Aged; Allopurinol; Biomarkers; Chronic Disease; Drug Therapy, Combination; Extracellular Matrix; Female; Fluorobenzenes; Free Radical Scavengers; Heart Failure; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Middle Aged; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Tissue Inhibitor of Metalloproteinase-1; Tissue Inhibitor of Metalloproteinase-2	2010
Effects of rosuvastatin on atrial fibrillation occurrence: ancillary results of the GISSI-HF trial. European heart journal, 2009, Volume: 30, Issue:19 Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Chronic Disease; Double-Blind Method; Drug Therapy, Combination; Fatty Acids, Omega-3; Female; Fluorobenzenes; Heart Failure; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kaplan-Meier Estimate; Male; Middle Aged; Pyrimidines; Risk Factors; Rosuvastatin Calcium; Sulfonamides; Treatment Outcome	2009
Effect of simvastatin vs. rosuvastatin on adiponectin and haemoglobin A1c levels in patients with non-ischaemic chronic heart failure. European journal of heart failure, 2009, Volume: 11, Issue:12 Topics: Adiponectin; Aged; C-Reactive Protein; Chronic Disease; Female; Fluorobenzenes; Glycated Hemoglobin; Heart Failure; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipoproteins, LDL; Male; Middle Aged; Natriuretic Peptide, Brain; Pyrimidines; Rosuvastatin Calcium; Simvastatin; Sulfonamides	2009
Plasma concentration of amino-terminal pro-brain natriuretic peptide in chronic heart failure: prediction of cardiovascular events and interaction with the effects of rosuvastatin: a report from CORONA (Controlled Rosuvastatin Multinational Trial in Heart Journal of the American College of Cardiology, 2009, Nov-10, Volume: 54, Issue:20 Topics: Aged; Aged, 80 and over; Female; Fluorobenzenes; Heart Failure; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipoproteins; Male; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments; Prognosis; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Triglycerides	2009
Effects of rosuvastatin on myeloperoxidase levels in patients with chronic heart failure: a randomized placebo-controlled study. Atherosclerosis, 2010, Volume: 210, Issue:1 Topics: Aged; Allopurinol; Biomarkers; Cholesterol; Cholesterol, LDL; Chronic Disease; Female; Fluorobenzenes; Heart Failure; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Male; Peroxidase; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Triglycerides	2010
An economic evaluation of rosuvastatin treatment in systolic heart failure: evidence from the CORONA trial. European journal of heart failure, 2010, Volume: 12, Issue:1 Topics: Aged; Cardiopulmonary Bypass; Cost-Benefit Analysis; Costs and Cost Analysis; Female; Fluorobenzenes; Heart Failure; Heart Transplantation; Hospital Mortality; Hospitalization; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Prospective Studies; Pyrimidines; Rosuvastatin Calcium; Sulfonamides	2010
Why did high-dose rosuvastatin not improve cardiac remodeling in chronic heart failure? Mechanistic insights from the UNIVERSE study. International journal of cardiology, 2011, Feb-03, Volume: 146, Issue:3 Topics: Chronic Disease; Female; Fluorobenzenes; Heart Failure; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Prospective Studies; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Ventricular Remodeling	2011
Effects of rosuvastatin on coronary flow reserve and metabolic mismatch in patients with heart failure (from the CORONA Study). The American journal of cardiology, 2010, Feb-15, Volume: 105, Issue:4 Topics: Aged; Aged, 80 and over; Biomarkers; C-Reactive Protein; Cholesterol, HDL; Cholesterol, LDL; Coronary Circulation; Dipyridamole; Exercise Test; Female; Fluorobenzenes; Fluorodeoxyglucose F18; Heart Failure; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipoproteins; Male; Myocardium; Netherlands; Pilot Projects; Pyrimidines; Radiopharmaceuticals; Rosuvastatin Calcium; Sulfonamides; Tomography, Emission-Computed; Vasodilator Agents	2010
High-dose rosuvastatin in chronic heart failure promotes vasculogenesis, corrects endothelial function, and improves cardiac remodeling--results from a randomized, double-blind, and placebo-controlled study. International journal of cardiology, 2011, Jan-07, Volume: 146, Issue:1 Topics: Administration, Oral; Aged; Cells, Cultured; Chronic Disease; Double-Blind Method; Drug Administration Schedule; Endothelium, Vascular; Female; Fluorobenzenes; Heart Failure; Humans; Male; Middle Aged; Neovascularization, Physiologic; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Ventricular Remodeling	2011
Prognostic value of osteoprotegerin in chronic heart failure: The GISSI-HF trial. American heart journal, 2010, Volume: 160, Issue:2 Topics: Aged; Female; Fluorobenzenes; Fluoroimmunoassay; Heart Failure; Hospitalization; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Italy; Male; Middle Aged; Osteoprotegerin; Prognosis; Proportional Hazards Models; Pyrimidines; Rosuvastatin Calcium; Sulfonamides	2010
Coenzyme Q10, rosuvastatin, and clinical outcomes in heart failure: a pre-specified substudy of CORONA (controlled rosuvastatin multinational study in heart failure). Journal of the American College of Cardiology, 2010, Oct-05, Volume: 56, Issue:15 Topics: Aged; Aged, 80 and over; Biomarkers; Female; Fluorobenzenes; Follow-Up Studies; Heart Failure; Hospitalization; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Internationality; Male; Middle Aged; Prospective Studies; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Treatment Outcome; Ubiquinone	2010
Effects of n-3 polyunsaturated fatty acids and of rosuvastatin on left ventricular function in chronic heart failure: a substudy of GISSI-HF trial. European journal of heart failure, 2010, Volume: 12, Issue:12 Topics: Aged; Analysis of Variance; Fatty Acids, Omega-3; Female; Fluorobenzenes; Health Status Indicators; Heart Failure; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Prognosis; Pyrimidines; Rosuvastatin Calcium; Stroke Volume; Sulfonamides; Treatment Outcome; Ultrasonography; Ventricular Function, Left	2010
Effects of rosuvastatin and allopurinol on circulating endothelial progenitor cells in patients with congestive heart failure: the impact of inflammatory process and oxidative stress. Atherosclerosis, 2011, Volume: 214, Issue:1 Topics: AC133 Antigen; Aged; Allopurinol; Antigens, CD; Antigens, CD34; Endothelial Cells; Enzyme Inhibitors; Female; Fluorobenzenes; Glycoproteins; Heart Failure; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Male; Middle Aged; Oxidative Stress; Peptides; Peroxidase; Pyrimidines; Rosuvastatin Calcium; Stem Cells; Sulfonamides; Vascular Endothelial Growth Factor Receptor-2; Xanthine Oxidase	2011
Osteoprotegerin predicts progression of chronic heart failure: results from CORONA. Circulation. Heart failure, 2011, Volume: 4, Issue:2 Topics: Aged; Aged, 80 and over; Biomarkers; Chronic Disease; Europe; Female; Fluorobenzenes; Heart Failure; Hospitalization; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kaplan-Meier Estimate; Lipids; Male; Middle Aged; Osteoprotegerin; Predictive Value of Tests; Proportional Hazards Models; Pyrimidines; Risk Assessment; Risk Factors; Rosuvastatin Calcium; Sulfonamides; Time Factors; Treatment Outcome	2011
The association between neutrophil gelatinase-associated lipocalin and clinical outcome in chronic heart failure: results from CORONA. Journal of internal medicine, 2012, Volume: 271, Issue:5* Topics: Acute-Phase Proteins; Aged; Apolipoprotein A-I; Biomarkers; C-Reactive Protein; Chronic Disease; Female; Fluorobenzenes; Glomerular Filtration Rate; Heart Failure; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipocalin-2; Lipocalins; Male; Middle Aged; Multivariate Analysis; Natriuretic Peptide, Brain; Norway; Patient Readmission; Peptide Fragments; Predictive Value of Tests; Prognosis; Proto-Oncogene Proteins; Pyrimidines; Rosuvastatin Calcium; Severity of Illness Index; Sulfonamides	2012
Pentraxin-3 in chronic heart failure: the CORONA and GISSI-HF trials. European journal of heart failure, 2012, Volume: 14, Issue:9 Topics: Aged; C-Reactive Protein; Chronic Disease; Double-Blind Method; Female; Fluorobenzenes; Heart Failure; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Male; Middle Aged; Prognosis; Proportional Hazards Models; Pyrimidines; Risk Assessment; Rosuvastatin Calcium; Serum Amyloid P-Component; Sulfonamides	2012
Soluble glycoprotein 130 predicts fatal outcomes in chronic heart failure: analysis from the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA). Circulation. Heart failure, 2013, Volume: 6, Issue:1 Topics: Aged; Biomarkers; Cytokine Receptor gp130; Female; Fluorobenzenes; Follow-Up Studies; Heart Failure; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Interleukin-6; Male; Middle Aged; Prognosis; Pyrimidines; Retrospective Studies; Rosuvastatin Calcium; Sulfonamides; Survival Rate	2013
Rationale and design of the GISSI heart failure trial: a large trial to assess the effects of n-3 polyunsaturated fatty acids and rosuvastatin in symptomatic congestive heart failure. European journal of heart failure, 2004, Volume: 6, Issue:5 Topics: Fatty Acids, Omega-3; Fatty Acids, Unsaturated; Fluorobenzenes; Heart Failure; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Pyrimidines; Randomized Controlled Trials as Topic; Research Design; Rosuvastatin Calcium; Sulfonamides; Triglycerides	2004
A statin in the treatment of heart failure? Controlled rosuvastatin multinational study in heart failure (CORONA): study design and baseline characteristics. European journal of heart failure, 2005, Volume: 7, Issue:6 Topics: Age Factors; Aged; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Fluorobenzenes; Follow-Up Studies; Heart Failure; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; International Cooperation; Male; Middle Aged; Probability; Prospective Studies; Pyrimidines; Risk Assessment; Rosuvastatin Calcium; Severity of Illness Index; Sulfonamides; Survival Analysis; Treatment Outcome	2005
Double-blind, randomized, placebo-controlled study of high-dose HMG CoA reductase inhibitor therapy on ventricular remodeling, pro-inflammatory cytokines and neurohormonal parameters in patients with chronic systolic heart failure. Journal of cardiac failure, 2007, Volume: 13, Issue:1 Topics: Adult; Aged; Chronic Disease; Cytokines; Double-Blind Method; Female; Fluorobenzenes; Heart Failure; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Neurotransmitter Agents; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Systole; Ventricular Remodeling	2007
Rosuvastatin in older patients with systolic heart failure. The New England journal of medicine, 2007, Nov-29, Volume: 357, Issue:22 Topics: Aged; Cardiovascular Diseases; Female; Fluorobenzenes; Follow-Up Studies; Heart Failure; Hospitalization; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Myocardial Ischemia; Proportional Hazards Models; Pyrimidines; Rosuvastatin Calcium; Single-Blind Method; Sulfonamides; Systole; Treatment Outcome	2007
[Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA)]. Kardiologiia, 2008, Volume: 48, Issue:1 Topics: Aged; Aged, 80 and over; Chronic Disease; Female; Fluorobenzenes; Heart Failure; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Pyrimidines; Rosuvastatin Calcium; Russia; Stroke Volume; Sulfonamides; Survival Rate; Treatment Outcome	2008

Other Studies

40 other study(ies) available for fluorobenzenes and Cardiac Failure

Article	Year
Effect of rosuvastatin on fatigue in patients with heart failure. Journal of the American College of Cardiology, 2013, Mar-12, Volume: 61, Issue:10 Topics: Fatigue; Fluorobenzenes; Heart Failure; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Logistic Models; Pyrimidines; Randomized Controlled Trials as Topic; Retrospective Studies; Rosuvastatin Calcium; Sulfonamides	2013
Regional differences in heart failure with preserved ejection fraction trials: when nephrology meets cardiology but east does not meet west. Circulation, 2015, Jan-06, Volume: 131, Issue:1 Topics: Benzimidazoles; Biphenyl Compounds; Female; Fluorobenzenes; Geography; Heart Failure; Humans; Internationality; Irbesartan; Male; Mineralocorticoid Receptor Antagonists; Patients; Pyrimidines; Rosuvastatin Calcium; Spironolactone; Stroke Volume; Sulfonamides; Tetrazoles	2015
Stroke and anticoagulation in heart failure without atrial fibrillation: from risk to opportunity. Circulation, 2015, Apr-28, Volume: 131, Issue:17 Topics: Fatty Acids, Omega-3; Female; Fluorobenzenes; Heart Failure; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Natriuretic Peptide, Brain; Peptide Fragments; Pyrimidines; Stroke; Sulfonamides	2015
Letter by Lin et al Regarding Article, "Risk of Stroke in Chronic Heart Failure Patients Without Atrial Fibrillation: Analysis of the Controlled Rosuvastatin in Multinational Trial Heart Failure (CORONA) and the Gruppo Italiano per lo Studio della Sopravv Circulation, 2015, Dec-01, Volume: 132, Issue:22 Topics: Fatty Acids, Omega-3; Female; Fluorobenzenes; Heart Failure; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Natriuretic Peptide, Brain; Peptide Fragments; Pyrimidines; Stroke; Sulfonamides	2015
Response to Letter Regarding Article, "Risk of Stroke in Chronic Heart Failure Patients Without Atrial Fibrillation: Analysis of the Controlled Rosuvastatin in Multinational Trial Heart Failure (CORONA) and the Gruppo Italiano per lo Studio della Sopravvi Circulation, 2015, Dec-01, Volume: 132, Issue:22 Topics: Fatty Acids, Omega-3; Female; Fluorobenzenes; Heart Failure; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Natriuretic Peptide, Brain; Peptide Fragments; Pyrimidines; Stroke; Sulfonamides	2015
Controlled Rosuvastatin Multinational Trial In Heart Failure (the positive negative trial). The American journal of cardiology, 2008, Jun-15, Volume: 101, Issue:12 Topics: Fluorobenzenes; Heart Failure; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Pyrimidines; Randomized Controlled Trials as Topic; Rosuvastatin Calcium; Sulfonamides; Treatment Outcome	2008
Lipophilicity and cardiovascular outcome in patients with CHF. American heart journal, 2008, Volume: 156, Issue:2 Topics: Aged; Atorvastatin; Fluorobenzenes; Heart Failure; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipids; Lovastatin; Pravastatin; Pyrimidines; Pyrroles; Rosuvastatin Calcium; Sulfonamides	2008
Impact of adherence to statins on chronic heart failure in primary prevention. British journal of clinical pharmacology, 2008, Volume: 66, Issue:5 Topics: Aged; Atorvastatin; Case-Control Studies; Databases, Factual; Female; Fluorobenzenes; Heart Failure; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Logistic Models; Lovastatin; Male; Middle Aged; Patient Compliance; Pravastatin; Primary Prevention; Pyrimidines; Pyrroles; Risk; Rosuvastatin Calcium; Simvastatin; Sulfonamides; Treatment Outcome	2008
Beyond coronary artery disease: rosuvastatin in older patients with ischemic systolic heart failure. Journal of the American Geriatrics Society, 2008, Volume: 56, Issue:7 Topics: Aged; Cholesterol; Coronary Disease; Dementia; Fluorobenzenes; Geriatrics; Heart Failure; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Middle Aged; Pyrimidines; Randomized Controlled Trials as Topic; Rosuvastatin Calcium; Sulfonamides; Ventricular Dysfunction, Left	2008
Clinical trials update from European Society of Cardiology meeting 2008: TIME-CHF, BACH, BEAUTIFUL, GISSI-HF, and HOME-HF. European journal of heart failure, 2008, Volume: 10, Issue:12 Topics: Benzazepines; Biomarkers; Cardiology; Europe; Fatty Acids, Unsaturated; Fluorobenzenes; Heart Failure; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Ivabradine; Natriuretic Peptide, Brain; Pyrimidines; Randomized Controlled Trials as Topic; Rosuvastatin Calcium; Societies, Medical; Sulfonamides	2008
Going for gold, from Beijing to Munich, highlights from the ESC 2008 Congress: BEAUTIFUL, GISSI-HF, and potential new therapies for acute decompensated heart failure. Cardiovascular therapeutics, 2008,Winter, Volume: 26, Issue:4 Topics: Adrenergic beta-Antagonists; Benzazepines; Cardiology; Drug Therapy, Combination; Fluorobenzenes; Heart Failure; Heart Rate; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Ivabradine; Multicenter Studies as Topic; Pyrimidines; Randomized Controlled Trials as Topic; Risk Factors; Rosuvastatin Calcium; Sulfonamides	2008
N-3 polyunsaturated fatty acids and statins in heart failure. Lancet (London, England), 2009, Jan-31, Volume: 373, Issue:9661 Topics: Aged; Fluorobenzenes; Health Status; Heart Failure; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Pyrimidines; Rosuvastatin Calcium; Severity of Illness Index; Sulfonamides; Treatment Failure	2009
[Rosuvastatin in patients with chronic heart failure]. Der Internist, 2009, Volume: 50, Issue:4 Topics: Aged; Chronic Disease; Double-Blind Method; Female; Fluorobenzenes; Heart Failure; Hospitalization; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Italy; Male; Proportional Hazards Models; Pyrimidines; Randomized Controlled Trials as Topic; Rosuvastatin Calcium; Sulfonamides	2009
[The GISSI-HF trial]. Giornale italiano di cardiologia (2006), 2009, Volume: 10, Issue:3 Topics: Double-Blind Method; Evidence-Based Medicine; Fluorobenzenes; Heart Failure; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Italy; Multicenter Studies as Topic; Pyrimidines; Randomized Controlled Trials as Topic; Research Design; Rosuvastatin Calcium; Sulfonamides; Treatment Outcome	2009
[Rosuvastatin has no effect on clinical outcomes in patients with heart failure. Results of the GISSI-HF trial]. Kardiologiia, 2009, Volume: 49, Issue:4 Topics: Fluorobenzenes; Heart Failure; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Pyrimidines; Randomized Controlled Trials as Topic; Rosuvastatin Calcium; Stroke Volume; Sulfonamides; Survival Rate; Treatment Outcome	2009
[Effect of therapy with rosuvastatin on circulating endothelial progenitor cells in patients with chronic heart failure]. Kardiologiia, 2009, Volume: 49, Issue:5 Topics: AC133 Antigen; Adult; Antigens, CD; Antigens, CD34; Dose-Response Relationship, Drug; Endothelium, Vascular; Female; Fluorobenzenes; Follow-Up Studies; Glycoproteins; Heart Failure; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Mesenchymal Stem Cells; Middle Aged; Peptides; Pyrimidines; Rosuvastatin Calcium; Stroke Volume; Sulfonamides; Treatment Outcome	2009
Statin therapy in patients with heart failure and preserved left ventricular function. Circulation journal : official journal of the Japanese Circulation Society, 2009, Volume: 73, Issue:7 Topics: C-Reactive Protein; Fluorobenzenes; Heart Failure; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipids; Pyrimidines; Rosuvastatin Calcium; Stroke Volume; Sulfonamides; Ventricular Function, Left	2009
Effect of rosuvastatin on cardiac remodeling, function, and progression to heart failure in hypertensive heart with established left ventricular hypertrophy. Hypertension (Dallas, Tex. : 1979), 2009, Volume: 54, Issue:3 Topics: Animals; Blood Pressure; Collagen; Disease Progression; Fibrosis; Fluorobenzenes; Heart; Heart Failure; Hemodynamics; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Hypertrophy, Left Ventricular; Myocardium; Organ Size; Pyrimidines; Random Allocation; Rats; Rats, Inbred Dahl; Rosuvastatin Calcium; Sulfonamides	2009
Rosuvastatin attenuates heart failure and cardiac remodelling in the ageing spontaneously hypertensive rat. Basic & clinical pharmacology & toxicology, 2009, Volume: 105, Issue:4 Topics: Aging; Animals; Blood Pressure; Diastole; Disease Models, Animal; Echocardiography; Fluorobenzenes; Heart; Heart Failure; Hypertension; Lipoproteins, LDL; Male; Pyrimidines; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Rats, Wistar; Rosuvastatin Calcium; Sulfonamides; Systole; Ventricular Remodeling	2009
Effect of n-3 polyunsaturated fatty acids and rosuvastatin in patients with heart failure: results of the GISSI-HF trial. Expert review of cardiovascular therapy, 2009, Volume: 7, Issue:7 Topics: Aged; Double-Blind Method; Fatty Acids, Omega-3; Female; Fluorobenzenes; Heart Failure; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Pyrimidines; Randomized Controlled Trials as Topic; Rosuvastatin Calcium; Sulfonamides; Treatment Outcome	2009
Can natriuretic peptides help identify heart failure patients for whom statins are beneficial? Journal of the American College of Cardiology, 2009, Nov-10, Volume: 54, Issue:20 Topics: Fluorobenzenes; Heart Failure; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Natriuretic Peptide, Brain; Peptide Fragments; Prognosis; Pyrimidines; Randomized Controlled Trials as Topic; Rosuvastatin Calcium; Sulfonamides	2009
Rosuvastatin and cardiovascular continuum when time is important. Journal of the American College of Cardiology, 2010, Apr-13, Volume: 55, Issue:15 Topics: Fluorobenzenes; Follow-Up Studies; Heart Failure; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Morbidity; Multicenter Studies as Topic; Natriuretic Peptide, Brain; Peptide Fragments; Prognosis; Protein Precursors; Pyrimidines; Randomized Controlled Trials as Topic; Risk Factors; Rosuvastatin Calcium; Sulfonamides; Survival Rate; Time Factors; United States	2010
Insulin resistance due to statin therapy: a potential contributor to the negation of statin-induced beneficial effects on cardiac remodelling in heart failure? International journal of cardiology, 2011, Feb-03, Volume: 146, Issue:3 Topics: Fluorobenzenes; Heart Failure; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Insulin Resistance; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Ventricular Remodeling	2011
Rosuvastatin added to standard heart failure therapy improves cardiac remodelling in heart failure rats with preserved ejection fraction. European journal of heart failure, 2010, Volume: 12, Issue:9 Topics: Animals; Blood Pressure; Disease Models, Animal; Echocardiography, Doppler, Color; Fluorobenzenes; Follow-Up Studies; Heart Failure; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Pilot Projects; Pyrimidines; Rats; Rats, Inbred SHR; Rosuvastatin Calcium; Stroke Volume; Sulfonamides; Treatment Outcome; Ventricular Remodeling	2010
Unending debate: statin dilemma in the management of heart failure. International journal of cardiology, 2011, Jan-07, Volume: 146, Issue:1 Topics: Endothelium, Vascular; Female; Fluorobenzenes; Heart Failure; Humans; Male; Neovascularization, Physiologic; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Ventricular Remodeling	2011
Coenzyme Q10 and statins in heart failure: the dog that didn't bark. Journal of the American College of Cardiology, 2010, Oct-05, Volume: 56, Issue:15 Topics: Animals; Biomarkers; Disease Models, Animal; Dogs; Fluorobenzenes; Heart Failure; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Ubiquinone	2010
Low coenzyme Q₁₀ levels and the outcome of statin treatment in heart failure. Journal of the American College of Cardiology, 2011, Apr-05, Volume: 57, Issue:14 Topics: Fluorobenzenes; Heart Failure; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Treatment Outcome; Ubiquinone	2011
Evaluation of LMI1195, a novel 18F-labeled cardiac neuronal PET imaging agent, in cells and animal models. Circulation. Cardiovascular imaging, 2011, Volume: 4, Issue:4 Topics: Animals; Cell Line, Tumor; Denervation; Disease Models, Animal; Fluorine Radioisotopes; Fluorobenzenes; Guanidines; Half-Life; Heart Failure; Humans; Image Processing, Computer-Assisted; Macaca fascicularis; Male; Neuroblastoma; Positron-Emission Tomography; Rabbits; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Sensitivity and Specificity; Tissue Distribution	2011
Rosuvastatin-attenuated heart failure in aged spontaneously hypertensive rats via PKCα/β2 signal pathway. Journal of cellular and molecular medicine, 2012, Volume: 16, Issue:12 Topics: Aging; Animals; Blood Pressure; Calcium-Binding Proteins; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Down-Regulation; Electron Transport Complex IV; Fluorobenzenes; Heart Failure; Hypertension; Male; Mitochondria; Myofibrils; Natriuretic Peptide, Brain; Peptide Fragments; Phosphorylation; Protein Kinase C beta; Protein Kinase C-alpha; Proteins; Pyrimidines; Rats; Rats, Inbred SHR; Rats, Inbred WKY; RNA, Messenger; Rosuvastatin Calcium; Ryanodine Receptor Calcium Release Channel; Sarcoplasmic Reticulum; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Signal Transduction; Sodium-Calcium Exchanger; Stroke Volume; Sulfonamides; Up-Regulation; Ventricular Function, Left	2012
Pleiotropic effects of long-term monotherapy with rosuvastatin in dogs with moderate heart failure. Cardiology, 2012, Volume: 123, Issue:3 Topics: Animals; Dogs; Dose-Response Relationship, Drug; Enzymes; Fluorobenzenes; Heart Failure; Heart Ventricles; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Proteins; Pyrimidines; Random Allocation; Rosuvastatin Calcium; Sulfonamides	2012
Pleiotropic effects of long-term monotherapy with rosuvastatin in dogs with moderate heart failure. Cardiology, 2013, Volume: 124, Issue:1 Topics: Animals; Disease Models, Animal; Dogs; Fluorobenzenes; Heart Failure; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Ventricular Remodeling	2013
The statin wars. Lancet (London, England), 2003, Nov-29, Volume: 362, Issue:9398 Topics: Coronary Disease; Fluorobenzenes; Heart Failure; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Pyrimidines; Randomized Controlled Trials as Topic; Rosuvastatin Calcium; Sulfonamides; Treatment Outcome	2003
Rosuvastatin reduces platelet activation in heart failure: role of NO bioavailability. Arteriosclerosis, thrombosis, and vascular biology, 2005, Volume: 25, Issue:5 Topics: Animals; Cell Adhesion Molecules; Chronic Disease; Disease Models, Animal; Endothelium, Vascular; Fluorobenzenes; Heart Failure; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Microfilament Proteins; Myocardial Infarction; Nitric Oxide; Phosphoproteins; Phosphorylation; Platelet Activation; Pyrimidines; Rats; Reactive Oxygen Species; Rosuvastatin Calcium; Sulfonamides; Superoxides; Thrombosis; Vasoconstriction; Vasodilation; Ventricular Function, Left	2005
Clinical trials update from the American College of Cardiology: Darbepoetin alfa, ASTEROID, UNIVERSE, paediatric carvedilol, UNLOAD and ICELAND. European journal of heart failure, 2006, Volume: 8, Issue:3 Topics: Carbazoles; Carvedilol; Child; Cholesterol, LDL; Clinical Trials as Topic; Darbepoetin alfa; Diuretics; Erythropoietin; Fluorobenzenes; Heart Failure; Humans; Myocardial Infarction; Propanolamines; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Ultrafiltration	2006
Chronic monotherapy with rosuvastatin prevents progressive left ventricular dysfunction and remodeling in dogs with heart failure. Journal of the American College of Cardiology, 2007, Aug-07, Volume: 50, Issue:6 Topics: Animals; Coronary Angiography; Dogs; Fluorobenzenes; Heart Failure; Hematopoietic Stem Cells; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Matrix Metalloproteinase 2; Myocardium; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Treatment Outcome; Tumor Necrosis Factor-alpha; Ventricular Dysfunction, Left; Ventricular Remodeling	2007
Statins for ischemic systolic heart failure. The New England journal of medicine, 2007, Nov-29, Volume: 357, Issue:22 Topics: Fluorobenzenes; Heart Failure; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Myocardial Ischemia; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Systole; Treatment Failure	2007
Clinical trials update from the American Heart Association 2007: CORONA, RethinQ, MASCOT, AF-CHF, HART, MASTER, POISE and stem cell therapy. European journal of heart failure, 2008, Volume: 10, Issue:1 Topics: Adrenergic beta-Antagonists; American Heart Association; Arrhythmias, Cardiac; Atrial Fibrillation; Cardiac Pacing, Artificial; Clinical Trials as Topic; Fluorobenzenes; Heart Failure; Humans; Metoprolol; Pyrimidines; Rosuvastatin Calcium; Stem Cell Transplantation; Sulfonamides; United States	2008
Rosuvastatin in older patients with systolic heart failure. The New England journal of medicine, 2008, Mar-20, Volume: 358, Issue:12 Topics: Coenzymes; Fluorobenzenes; Heart Failure; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Treatment Failure; Ubiquinone; Vascular Diseases	2008
[No reason to start treatment with statins in patients with moderate to severe heart failure]. Nederlands tijdschrift voor geneeskunde, 2008, Mar-01, Volume: 152, Issue:9 Topics: C-Reactive Protein; Cholesterol, LDL; Drug Interactions; Fluorobenzenes; Heart Failure; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Pyrimidines; Risk Assessment; Rosuvastatin Calcium; Sulfonamides; Treatment Outcome	2008
[Statin therapy for systolic heart failure. The CORONA trial (Controlled Rosuvastatin Multinational Trial in Heart Failure)]. Der Internist, 2008, Volume: 49, Issue:7 Topics: Aged; Cardiovascular Diseases; Controlled Clinical Trials as Topic; Female; Fluorobenzenes; Follow-Up Studies; Heart Failure; Hospitalization; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Myocardial Ischemia; Proportional Hazards Models; Pyrimidines; Rosuvastatin Calcium; Single-Blind Method; Sulfonamides; Systole; Treatment Outcome	2008